FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2950595872> ?p ?o ?g. }

• W2950595872 abstract "Melatonin (N-acetyl-5-methoxytryptamine) modulates circadian rhythms and sleep-wake cycles, primarily via activation of the MT1 and MT2 melatonin receptors which exhibit distinct pharmacological profiles. The MT1/MT2 melatonin receptor ligand, luzindole (LUZ), delays re-entrainment of running wheel activity following an advance of dark onset via the MT1, and exerts antidepressant-like effects via the MT2 melatonin receptor. Our goal is to design and synthesize novel analogues with at least 50-fold selectivity for either MT1 or MT2 and a pharmacological profile on each receptor compatible with that of LUZ (ei., antagonist/inverse agonists at MT1; antagonist/partial agonists at MT2) to potentially mimic distinct receptor-mediated behaviors. Our strategy is to assess structure-activity relationships of indolealkyl amides to identify optimal functional groups that yield a more defined efficacy. A series of b-methyl, b,b-dimethyl and a-methyl C3-side chain functionalized indolealkyl amides, incorporating C2-Me, C2-Ph or C2-H substituents were prepared. Four C5-non-methoxylated derivatives of melatonin, but with its side chain translocated from C3 to C2, were also synthesized. The compounds were tested in vitro for competition with 2-[125I]-iodomelatonin (100 pM) binding at hMT1 and hMT2 receptors stably expressed in CHO cells to assess binding affinities (Ki) as well as apparent intrinsic efficacy in the presence of GTP (100 μM). The apparent efficacy of LUZ in GTP-shift binding assays with 2-[125I]-iodomelatonin shows an antagonist/inverse agonist profile at MT1 (KiGTP/Control: 0.20 ± 0.08, n=3), and an antagonist/partial agonist profile at MT2 (KiGTP/Control: 1.5 ± 0.4, n=4). The high affinity of the various analogues was dependent on the presence of b- and α-substituents, and the nature of the C2-functionality. A C2-Ph analogue, named ATBT-23 exhibited high affinity and selectivity for the hMT2 receptor. Indeed, ATBT-23 showed 190-fold selectivity for the MT2 receptor (MT1 Ki: 2,794 nM, MT2 Ki: 15 nM, KihMT1/KihMT2 Ratio: 190, n=4). This selectivity is distinct from that of LUZ which demonstrates approximately 26-fold affinity for the MT2 receptor. However, GTP shift binding assays revealed apparent affinity ratios compatible with ATBT-23 being a melatonin receptor antagonist/weak inverse agonist at hMT1 and an antagonist/partial agonist at hMT2 receptors, similar to non-selective LUZ. Brain penetration determined by ex vivo binding as well as the in vivo behavioral profile for the MT2 selective analogue ATBT-23 on circadian re-entrainment and depressive-like behaviors in C3H/HeN mice will be reported and compared with the behavioral profile of LUZ and other melatonin receptor type-selective analogues. ATBT-23 and newly synthesized analogues could signify a novel class of melatonin receptor ligands with higher affinity and efficacy yet similar pharmacology to LUZ, for the treatment of circadian sleep and depressive disorders. Support or Funding Information Supported by the Jacobs School of Medicine and Biomedical Sciences to MLD. This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal." @default.
• W2950595872 created "2019-06-27" @default.
• W2950595872 creator A5002979350 @default.
• W2950595872 creator A5008325691 @default.
• W2950595872 creator A5009290561 @default.
• W2950595872 creator A5010613697 @default.
• W2950595872 creator A5041948016 @default.
• W2950595872 creator A5049499127 @default.
• W2950595872 creator A5051248723 @default.
• W2950595872 creator A5072768172 @default.
• W2950595872 creator A5085833848 @default.
• W2950595872 creator A5088644120 @default.
• W2950595872 creator A5089657831 @default.
• W2950595872 date "2019-04-01" @default.
• W2950595872 modified "2023-09-27" @default.
• W2950595872 title "Side Chain Substituted Indolealkyl Amides as Potent Melatonin Receptor Ligands" @default.
• W2950595872 doi "https://doi.org/10.1096/fasebj.2019.33.1_supplement.lb43" @default.
• W2950595872 hasPublicationYear "2019" @default.
• W2950595872 type Work @default.
• W2950595872 sameAs 2950595872 @default.
• W2950595872 citedByCount "0" @default.
• W2950595872 crossrefType "journal-article" @default.
• W2950595872 hasAuthorship W2950595872A5002979350 @default.
• W2950595872 hasAuthorship W2950595872A5008325691 @default.
• W2950595872 hasAuthorship W2950595872A5009290561 @default.
• W2950595872 hasAuthorship W2950595872A5010613697 @default.
• W2950595872 hasAuthorship W2950595872A5041948016 @default.
• W2950595872 hasAuthorship W2950595872A5049499127 @default.
• W2950595872 hasAuthorship W2950595872A5051248723 @default.
• W2950595872 hasAuthorship W2950595872A5072768172 @default.
• W2950595872 hasAuthorship W2950595872A5085833848 @default.
• W2950595872 hasAuthorship W2950595872A5088644120 @default.
• W2950595872 hasAuthorship W2950595872A5089657831 @default.
• W2950595872 hasConcept C116569031 @default.
• W2950595872 hasConcept C134018914 @default.
• W2950595872 hasConcept C135285700 @default.
• W2950595872 hasConcept C170493617 @default.
• W2950595872 hasConcept C185592680 @default.
• W2950595872 hasConcept C2776885963 @default.
• W2950595872 hasConcept C2778182776 @default.
• W2950595872 hasConcept C2778938600 @default.
• W2950595872 hasConcept C2781269140 @default.
• W2950595872 hasConcept C2781416619 @default.
• W2950595872 hasConcept C38533456 @default.
• W2950595872 hasConcept C55493867 @default.
• W2950595872 hasConcept C71240020 @default.
• W2950595872 hasConcept C86803240 @default.
• W2950595872 hasConcept C86811712 @default.
• W2950595872 hasConcept C89951826 @default.
• W2950595872 hasConcept C98274493 @default.
• W2950595872 hasConceptScore W2950595872C116569031 @default.
• W2950595872 hasConceptScore W2950595872C134018914 @default.
• W2950595872 hasConceptScore W2950595872C135285700 @default.
• W2950595872 hasConceptScore W2950595872C170493617 @default.
• W2950595872 hasConceptScore W2950595872C185592680 @default.
• W2950595872 hasConceptScore W2950595872C2776885963 @default.
• W2950595872 hasConceptScore W2950595872C2778182776 @default.
• W2950595872 hasConceptScore W2950595872C2778938600 @default.
• W2950595872 hasConceptScore W2950595872C2781269140 @default.
• W2950595872 hasConceptScore W2950595872C2781416619 @default.
• W2950595872 hasConceptScore W2950595872C38533456 @default.
• W2950595872 hasConceptScore W2950595872C55493867 @default.
• W2950595872 hasConceptScore W2950595872C71240020 @default.
• W2950595872 hasConceptScore W2950595872C86803240 @default.
• W2950595872 hasConceptScore W2950595872C86811712 @default.
• W2950595872 hasConceptScore W2950595872C89951826 @default.
• W2950595872 hasConceptScore W2950595872C98274493 @default.
• W2950595872 hasIssue "S1" @default.
• W2950595872 hasLocation W29505958721 @default.
• W2950595872 hasOpenAccess W2950595872 @default.
• W2950595872 hasPrimaryLocation W29505958721 @default.
• W2950595872 hasRelatedWork W2024774774 @default.
• W2950595872 hasRelatedWork W2028236518 @default.
• W2950595872 hasRelatedWork W2029821895 @default.
• W2950595872 hasRelatedWork W2030805789 @default.
• W2950595872 hasRelatedWork W2045644996 @default.
• W2950595872 hasRelatedWork W2055296962 @default.
• W2950595872 hasRelatedWork W2074696931 @default.
• W2950595872 hasRelatedWork W2113921687 @default.
• W2950595872 hasRelatedWork W2950595872 @default.
• W2950595872 hasRelatedWork W4281739791 @default.
• W2950595872 hasVolume "33" @default.
• W2950595872 isParatext "false" @default.
• W2950595872 isRetracted "false" @default.
• W2950595872 magId "2950595872" @default.
• W2950595872 workType "article" @default.